A longitudinal study examining the serological responses of SARS-CoV-2 mRNA vaccine recipients showed that, in addition to IgG, antigen-specific IgA also reached levels effective in preventing infection and transmission; however, the authors reported that spike-specific serum IgA levels decreased significantly faster than spike-specific IgG (p < 0.002). The gene discussed is CD79A; the disease is infection.